SMAD2 and lung cancer: Specifically, TGF-β can trigger the classic TGF-β/Smad signaling pathway by intensifying Smad2/3 phosphorylation, thereby igniting the EMT process in various malignancies such as esophageal, gastric, and lung cancers [37–40].